Hepatitis B virus carrier rate, prevalence and susceptibility and impact of immunization program among households in the city of Taiz, Yemen

Vaccine

Volumn 30, Issue 37, 2012, Pages 5564-5568

  Sallam, T A ^a   Raja'a, Y A ^a   Bahaj, S ^b   Al Shami, A M ^c   Lu, M ^d   Roggendorf, M ^d   Tong, C Y W ^e  

^a SANA A UNIVERSITY   (Yemen)

^b Dhamar University   (Yemen)

^c Ministry of Public Health and Population   (Yemen)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Carrier rate; Community based; Hepatitis B virus; Prevalence susceptibility; Taiz; Yemen

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; GROUPS BY AGE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE STATUS; INFANT; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; VIRUS CARRIER; VIRUS IMMUNITY; VIRUS LOAD; YEMEN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARRIER STATE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FAMILY CHARACTERISTICS; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MALE; MIDDLE AGED; PROGRAM EVALUATION; YEMEN; YOUNG ADULT;

EID: 84864290925     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.06.008     Document Type: Article

References (37)

1. Kane M. Global status of hepatitis B immunization. Lancet 1996, 348:696.
2. Ott J.J., Stevens G.A., Groeger J., Wiersma S.T. Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012, 30:2212-2219.
3. Juszczyk J. Clinical course and consequences of hepatitis B infection. Vaccine 2000, 18:S23-S25.
4. Dienstag J.L. Hepatitis B virus infection. N Engl J Med 2008, 359:1486-1500.
5. Chu C.M., Liau Y.F. Natural history of chronic hepatitis B virus infection: an immunopathological study. J Gastroenterol Hepatol 1997, 12:218-222.
6. Ganem D., Prince A.M. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004, 350:1118-1129.
7. Margolis H.S., Alter M.J., Hadler S.C. Viral hepatitis. Viral Infections of Humans 1997, 363-418. Plenum Publishing Corporation, New York. A.S. Evans, R.A. Kaslow (Eds.).
8. Gunaid A.A., Nasher T.M., El-Gunaid A.M., Hill M., Dayto R., Pal A., et al. Acute sporadic hepatitis in the Republic of Yemen. J Med Virol 1997, 51:64-66.
9. Bajubair M., Elrub A.A., Bather G. Hepatic viral infections in Yemen between 2000-2005. Saudi Med J 2008, 29:871-874.
10. Scott D.A., Buraris J., Al-Ouzeib H.D. Seroepidemiological survey of viral hepatitis in the Yemen Arab Republic. Trans Roy Soc Trop Med Hyg 1990, 84:82-84.
11. Al-Nassiri K.A., Raja'a Y.A. Hepatitis B infection in Yemenis in Sana'a: pattern and risk factors. East Mediterr Health J 2001, 7:147-152.
12. Al-Shamahy H.A. Prevalence of hepatitis B surface antigen and risk factors of HBV infection in healthy mothers in Sana'a. YMJ 1999, 3:78-81.
13. Al-Robasi A.A., Al-Harbi L. Prevalence of markers of human immunodeficiency virus (HIV-1), hepatitis B and syphilis among blood donors in Yemen. YMJ 1996, 2:58-60.
14. Sallam T.A., Tong C.Y.W. Two distinct types of hepatitis B virus core promoter variants in Yemeni blood donors. J Med Virol 2002, 68:328-334.
15. Hanash S.H., Al-Jaufy A.Y. Hepatitis B virus markers and risk factors among health care workers in Sana'a hospitals. Bull. Fac. Sc. Sana'a University 2000, 14:135-149.
16. Sallam T.A., Tong C.Y.W., Cuevas L.E., Raja'a Y.A., Othman A.M., Al-Kharsa K.R. Prevalence of blood-borne viral hepatitis in different communities in Yemen. Epidemiol Infect 2003, 231:771-775.
17. El Guneid A.M., Gunaid A.A., O'Neill A.M., Zureikat N.I., Coleman J.C., Murray-Lyon I.M. Prevalence of hepatitis B, C, and D virus markers in Yemeni patients with chronic liver disease. J Med Virol 1993, 40:330-333.
18. Abdel Raheem S.M., Abou-Lohum T.S., El-Didy H., El-Eriani H., Mansour S., Hafez A.S. Hepatitis B infection in Sana'a city, Republic of Yemen. Prevalence among pregnant women and materno-foetal transmission. J Egypt Public Health Assoc 1991, 66(5-6):491-503.
19. Al-Shamahy H. Prevalence of hepatitis B surface antigen and risk factors of HBV infection in a sample of healthy mothers and their infants in Sana'a, Yemen. Ann Saudi Med 2000, 20:464-466.
20. Shidrawi R., Al-Huraibi A.A., Al-Haimi M.A., Dayton R., Murray-Lyon I.M. Seroprevalence of markers of viral hepatitis in Yemeni healthcare workers. J Med Virol 2004, 73:562-565.
21. Bawazir A.A., Parry C.M., Hart C.A., Sallam T.A., Beeching N., Cuevas L.E. Seroepidemiology and risk factors of hepatitis B virus in Aden, Yemen. J. Infect Public Health 2011, 4:48-54.
22. Wasley A., Kruszon-Moran D., Kuhnert W., Simard E.P., Finelli L., McQuillan G., et al. The prevalence of Hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis 2010, 202:192-201.
23. Liang X., Bi S., Yang W., Wang L., Cui G., Cui F., et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis 2009, 200:39-47.
24. Romano' L., Paladini S., Van Damme P., Zanetti A.R. The worldwide impact of vaccination on the control and protection of viral hepatitis B. Dig Liver Dis 2011, 43(Suppl. 1):S2-S7.
25. Mu S.C., Wang G.M., Jow G.M., Chen B.F. Impact of universal vaccination on intrafamilial transmission of hepatitis B virus. J Med Virol 2011, 83:783-790.
26. Bialek S.R., Helgenberger L., Fischer G.E., Bower W.A., Konelios M., Chaine J.P., et al. Impact of routine hepatitis B immunization on the prevalence of chronic hepatitis B virus infection in the marshall islands and the federated States of micronesia. Pediatr Infect Dis J 2010, 29:18-22.
27. WHO country page. Yemen reported immunization coverage. [accessed 28 April]. http://apps.who.int/immunization%20monitoring/en/globalsummary/%20timeseries/tscoveragebycountry.cfm%3FC=YEM%5D.
28. UNICEF, Ministry of Public Health & Population, Republic of Yemen. Vaccination coverage survey and EPI Evaluation for the UNICEF Community Development Project Area Yemen July 2-21, 2004. [accessed 28 April]. http://www.mophp-%20ye.org/DocDB/resdetail.aspx%3FR%20ID=532%5D.
29. Sallam T.A., Cuevas L.E., Tong C.Y. Increase in susceptibility of young adults to Hepatitis B infection in the Republic of Yemen. Trans R Soc Trop Med Hyg 2003, 97:302-304.
30. Central Statistic Organization. 2004 census. Ministry of Planning and Developments; 2004.
31. Chen C.H., Changchien C.S., Lee C.M., Hung C.H., Hu T.H., Wang J.H., et al. Combined mutations in pre-s/surface and core promoter/precore regions of Hepatitis B virus increase the risk of hepatocellular carcinoma a case-control study. J Infect Dis 2008, 198:1634-1642.
32. Zarski J.P., Ganem D., Wright T.L. Hepatitis B Virus. Clinical Virology 2002, 623-657. ASM Press, Washington DC. D.D. Richman, R.J. Whitley, F.J. Hayden (Eds.).
33. Bio-Rad Laboratories. EIA for Qualitative Determination of HBeAg and/or Anti-HBe, BIO-RAD. [accessed on 18 May]. http://www3.bio-%20rad.com/(/br_category.jsp%3F(B%2FMicroplate%2FMonolisa(Ab+PLUS+Assay.
34. Deltenre P., Laleman W., Van Gossum M., Lenaerts A., Colle I., Michielsen P., et al. HBV infection in Belgium: results of the BASL observatory of 1,456 HBsAg carriers. Acta Gastroenterol Belg 2012, 75:35-41.
35. Nelson C.M., Wibisono H., Purwanto H., Mansyur, Moniaga V., Widjaya A. Hepatitis B vaccine freezing in the Indonesian cold chain: evidence and solutions. Bull World Health Organ 2004, 82:99-105.
36. Passos A.M., Treitinger A., Spada C. Hepatitis B immunity and vaccination coverage among young adult males in the air force in South Brazil. Vaccine 2011, 29:9284-9288.
37. Campagna M., Siddu A., Meloni A., Murru C., Masia G., Coppola R.C. Epidemiological impact of mandatory vaccination against Hepatitis B in Italian young adults. Hepat Mon 2011, 11:750-752.